Sarepta Therapeutics to Present at Upcoming Investor Conferences
Get Alerts SRPT Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at three upcoming virtual investor conferences:
- Cowen 42nd Annual Health Care Conference on Wednesday, March 9, 2022 at 2:10 p.m. E.T.
- Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022 at 3:20 p.m. E.T.
- Guggenheim 3rd Annual Genomic Medicines and Rare Disease Day on Thursday, March 31, 2022 at 12 p.m. E.T.
The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Sarepta TherapeuticsSarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.
Internet Posting of InformationWe routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
Source: Sarepta Therapeutics, Inc.
Investor Contact: Ian Estepan, 617-274-4052[email protected]
Media Contact: Tracy Sorrentino, 617-301-8566[email protected]
Source: Sarepta Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Announcement of drawings (CK95) - Totalkredit A/S
- Regarding AB Tewox partial early redemption of bonds
- Havila Shipping ASA: Contract extension with Equinor Energy for Havila Troll
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Twitter, Cowen & Co, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share